DELIVRXD LLC NPI 1558807495

NPI Details

DELIVRXD LLC is a community/retail pharmacy pharmacy in Tampa, FL. The provider is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes. DELIVRXD LLC NPI is 1558807495. The provider is registered as an organization entity type.
The provider Is Doing Business As Deliverxd Pharmacy.

The provider's business location address is:

4801 GEORGE RD STE 140
TAMPA, FL
ZIP 33634-297
Phone: (813) 932-6266
Fax: (813) 392-3556

The provider's authorized official is William Cecil Parker .
The authorized official title is Ceo and has the following contact phone number (813) 932-6266.

The CLIA number assigned to this NPI record is 10D2213565 - pharmacy with a certificate type of Certificate of Waiver.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count (HCPCS:K1034)
• Covid-19 vaccine administration inside a patient's home; reported only once per individual home per date of service when only covid-19 vaccine administration is performed at the patient's home (HCPCS:M0201)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Adm sarscv2 30mcg trs-sucr 1 (HCPCS:0051A)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc (HCPCS:U0002)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Adm sarscv2 30mcg trs-sucr 3 (HCPCS:0053A)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency (HCPCS:M0223)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Intravenous infusion, sotrovimab, includes infusion and post administration monitoring (HCPCS:M0247)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency (HCPCS:M0248)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0221)

The enumeration date for this NPI number is 1/17/2017 and was last updated on 7/15/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.